Similar articles

• [A new drug in the treatment of chronic arterial diseases of the limbs].

  Schmidt C, Royer RJ, Schmitt J. Schmidt C, et al. Sem Hop. 1978 Feb;54(4):210-3. Sem Hop. 1978. PMID: 208169 French. No abstract available.
• [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].

  Battke K, Buchwalsky R, Barmeyer J, Hoffmann G, Reindell H. Battke K, et al. Fortschr Med. 1978 Jul 20;96(26-27):1381-6. Fortschr Med. 1978. PMID: 669532 Clinical Trial. German. No abstract available.
• [Effect of bencyclane on the visual field in glaucoma].

  Szymaniak R, Szczypiński J, Sek B. Szymaniak R, et al. Klin Oczna. 1987 Mar;89(3):100-1. Klin Oczna. 1987. PMID: 3309448 Clinical Trial. Polish. No abstract available.
• [Chronic arterial insufficiency of lower limbs: treatment by bencyclan (fludilat) (author's transl)].

  Krähenbühl B. Krähenbühl B. Schweiz Rundsch Med Prax. 1975 May 20;64(20):632-4. Schweiz Rundsch Med Prax. 1975. PMID: 1099573 Clinical Trial. French. No abstract available.
• Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.

  Spitzer S, Bach R, Schieffer H. Spitzer S, et al. Int Angiol. 1992 Jul-Sep;11(3):204-10. Int Angiol. 1992. PMID: 1460355 Review.